JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 45(2011) N 3 p. 451-457;
Hongjiang He1, Dan Zhu2, Ji Sun1, Rong Pei1, Shenshan Jia1*

The novel protein TSR2 inhibits the transcriptional activity of nuclear factor-kB and induces apoptosis

1Department of Head and Neck Surgery, The Third Affiliated Hospital of Harbin Medical University, Heilongjiang 150081, China
2Department of Hemodialysis Center, First Affiliated Hospital of Harbin Medical University, Heilongjiang 150081, China

*dr_hippo@126.com
Received - 2010-03-13; Accepted - 2010-07-07

The nuclear factor- B (NF- B) pathway is involved in a variety of cellular functions, including cell proliferation, differentiation, development, oncogenesis, and apoptosis. In this study, we report on cloning and characterization of the human TSR2 (also known as 20S rRNA accumulation homolog), a protein containing a WGG motif, which has no known specific function, although this protein is conserved during evolution across different species. The cDNA sequence contains a 576 bp open reading frame, encoding a 191 amino acid protein with a predicted molecular mass of 20.9 kDa. Northern blot analysis revealed broad TSR2 mRNA expression in human tissues. Overexpression of TSR2 in human epidermal HEp-2 cells inhibited the transcriptional activity of NF- B, with or without tumor necrosis factor stimulus, and induced HEp-2 cell apoptosis. This data for the first time suggests that TSR2 is involved in the NF- B signaling pathway and may regulate apoptosis.

TSR2, nuclear factor-κB, apoptosis, laryngeal cancer



JMB-FOOTER RAS-JOURNALS